Advantage Investment Management’s NOV NOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$4K Hold
201
﹤0.01% 795
2019
Q2
$4K Hold
201
﹤0.01% 808
2019
Q1
$5K Hold
201
﹤0.01% 764
2018
Q4
$5K Hold
201
﹤0.01% 792
2018
Q3
$9K Hold
201
0.01% 731
2018
Q2
$9K Sell
201
-300
-60% -$12.1K 0.01% 669
2018
Q1
$18K Sell
501
-200
-29% -$7.33K 0.01% 572
2017
Q4
$25K Hold
701
0.01% 536
2017
Q3
$25K Sell
701
-125
-15% -$4.08K 0.01% 513
2017
Q2
$27K Buy
826
+125
+18% +$4.31K 0.01% 506
2017
Q1
$28K Sell
701
-310
-31% -$12.1K 0.01% 483
2016
Q4
$38K Buy
1,011
+110
+12% +$4.01K 0.01% 386
2016
Q3
$33K Hold
901
0.01% 412
2016
Q2
$30K Hold
901
0.01% 421
2016
Q1
$28K Buy
901
+400
+80% +$12.2K 0.01% 412
2015
Q4
$17K Hold
501
0.01% 494
2015
Q3
$19K Buy
501
+200
+66% +$8.18K 0.01% 461
2015
Q2
$15K Sell
301
-64
-18% -$3.29K 0.01% 519
2015
Q1
$18K Sell
365
-1,251
-77% -$67.8K 0.01% 490
2014
Q4
$106K Buy
+1,616
New +$113K 0.08% 202

Other funds holding NOV

Advantage Investment Management's NOV Position: Q3 2019 in Review

Advantage Investment Management held its NOV (NOV) position steady in Q3 2019 at 201 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #795.

Advantage Investment Management first reported a position in NOV in Q4 2014 and has held it in 20 quarters since. The position peaked at $106K in Q4 2014. 482 funds tracked by Wall St. Rank hold NOV as of Q3 2019.

  • Advantage Investment Management held 201 shares of NOV worth $4K as of Q3 2019.
  • Advantage Investment Management left its NOV share count unchanged in Q3 2019.
  • NOV made up ﹤0.01% of Advantage Investment Management's portfolio in Q3 2019, its #795 holding.
  • Advantage Investment Management first reported a position in NOV in Q4 2014 and has held it in 20 quarters since.
  • Advantage Investment Management's NOV position peaked at $106K in Q4 2014.
  • 482 funds tracked by Wall St. Rank held NOV as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.